📰 **enGene Therapeutics Inc. (ENGN) Discusses Pivotal Cohort Data from LEGEND Trial of Detalimogene in High-Risk NMIBC Transcript**

🔗 https://seekingalpha.com/article/4901996-engene-therapeutics-inc-engn-discusses-pivotal-cohort-data-from-legend-trial-of-detalimogene?source=feed_all_articles

#markets #news